Hong Kong Exchanges and Clearing Limited

FORM 2 - Corporate Substantial Shareholder Notice

Form Serial No:

CS20170808000035

1. Name of listed corporation:

Livzon Pharmaceutical Group Inc. - H Shares

2. Stock code:

01513

3. Class of shares:

H股

4. Number of issued shares in class:

189,268,768

5. Name of substantial shareholder:

健康元藥業集團股份有限公司

6. Registered office:

中國深圳市南山區高新北區郎山路17號健康元藥業集團大廈

7. Principal place of business in Hong Kong:

Nil

13. Exchange on which listed:

上海證券交易所

14. Name of listed parent and exchange on which parent is listed:

15. Date of relevant event:

28/07/2017
(dd/mm/yyyy)

16. Date when the substantial shareholder became aware of the relevant event/ interest in the shares (if later):


17. Details of relevant event:
	Relevant event code describing circumstances	Code describing capacity in which shares were/are held		Number of shares bought/sold or involved	Currency of transaction	On Exchange		Off Exchange
		Before relevant event	After relevant event			Highest price per share	Average price per share	Average consideration per share	Consideration code
Long position	115		205	22,307,420	HKD

18. Total shares immediately before the relevant event:

	Total number of shares	Percentage figure (%)
Long Position	74,358,067	51.07

19. Total shares immediately after the relevant event:

	Total number of shares	Percentage figure (%)
Long Position	96,665,487	51.07

20. Capacity in which interests disclosed in Box 19 are held:

Code describing capacity

Number of shares

205

Long position

96,665,487

21. Further information in respect of derivative interests:

Code describing derivatives	Number of shares
Nil

22. Further information in relation to interests of corporations controlled by substantial shareholder:

Name of controlled corporation

Address and place of incorporation

Name of controlling shareholder

% control

Direct interest

Number of shares

天誠實業有限公司

香港灣仔告士打道38號中國恆大中心13樓1301室註冊成立地點:香港

健康元藥業集團股份有限公司

100.00

Long position

96,665,487

23. Further information in relation to interests held by substantial shareholder jointly with another person:

Name of joint shareholder	Address	Number of shares
Nil

24. Further information from a trustee, or beneficiary of a trust, or a founder of a Discretionary Trust:

Names of Trust	Address	Status code	Number of shares
Nil

25. Further information from a party to an agreement under Section 317:

Names of other parties	Address	Number of shares
Nil

Total number of shares in which substantial shareholder is interested under section 317 and 318:

26. Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act:

Names	Address	Relationship Code	%
Nil

27. Date of filing this Form 2:

07/08/2017
(dd/mm/yyyy)

29. Number of attachments: